Recent Posts
- MicroRNA-Mediated Metastasis Suppression
- A New Explanation Of ‘Asian Paradox’
- Toward Bold New Anti-cancer Medicines
- Celsion And Yakult Honsha Announce Treatment Of First Patient In Japan In Celsion’s Global Phase III ThermoDox(R) Trial For Primary Liver Cancer
- $6.5 Million Gift To UCSF From Irwin And Joan Jacobs For Head And Neck Cancer Research
Random Posts
- New Multi-Use Device Can Shed Light On Oxygen Intake
- Damon Runyon Cancer Research Foundation Awards Prestigious Fellowships To 17 Top Young Scientists
- Whites at Highest Risk for Ewing's Sarcoma (CME/CE)
- ASCO: HPV Infection Linked to Better Outcome in Oropharyngeal Cancer
- Meta-Analysis Clarifies AML Treatment (CME/CE)
- American Association For Cancer Research Hosts Successful 100th Annual Meeting In Denver
- Formaldehyde Tied to Blood, Lymphatic Cancers (CME/CE)
- Bone Cancer Research Trust Calls For New Treatments For Bone Cancer
- Genes From Man's Best Friend May Help In The Search For A Cure For Brain Cancer
- ASCO: New Regimen Shows Promise in Advanced Renal Cell Carcinoma
Prescription Cancer Drugs
Shedding Light On Cancer Cells
Posted by: admin in Prescription Cancer Drugs on September 28th, 2009
Scientists label cells with coloured or glowing chemicals to observe how basic cellular activities differ between healthy and cancerous cells. Existing techniques for labelling cells are either too slow or too toxic to perform on live cells. Now, a study reviewed by Philip Dawson, a member of Faculty of 1000 Biology and leading authority in chemistry and cell biology, describes a novel labelling technique that uses a chemical reaction to make live cancer cells light up quickly and safely.
Researchers at Massachusetts General Hospital developed a two-step process to specifically tag cancer cells. First, chemically modified antibodies home in on cancer cells. Then a chemical reaction called cycloaddition transfers a dye onto the antibody making the cancer cells glow when viewed through a microscope.
The novel cycloaddition reaction is fast, very specific, and requires minimal manipulation of the cells. Dawson comments that, in combining antibody binding with the cycloaddition, “low signal-to-noise ratios are achieved”. This new labelling technique could be used to track the location and activity of anti-cancer drugs, the location of cancer-specific proteins within the cell, or to visualize cancer cells inside a living organism.
Dawson concludes that cycloaddition will allow scientists to observe live cancer cells in the body, leading to a better understanding of cancer’s basic processes.
The full text of this article is available at http://f1000biology.com/article/nztqpbh7bsrf6vb/id/1164570
Source:
Steve Pogonowski
Faculty of 1000: Biology and Medicine
No Comments »
No comments yet.
RSS feed for comments on this post. TrackBack URL
Leave a comment
You must be logged in to post a comment.





